Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow Quality Index
Guizhou Bailing Group Pharmaceutical Co Ltd cash flow quality index. Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Cash Flow Quality Index of 59.19x as of September 2025. Operating cash flow of CN¥294.76 Million exceeds net income of CN¥4.98 Million, indicating high earnings quality where cash backs reported profits. See Guizhou Bailing Group Pharmaceutical Co (002424) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2024)
Cash flow quality index of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2024. Historical Cash Flow Quality Index for Guizhou Bailing Group Pharmaceutical Co Ltd across 17 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Guizhou Bailing Group Pharmaceutical Co service its debt to assess how comfortably operating cash covers total debt obligations.
Guizhou Bailing Group Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2007–2024)
Guizhou Bailing Group Pharmaceutical Co Ltd cash flow quality index by year from 2007 to 2024. Year-by-year earnings quality comparison for Guizhou Bailing Group Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Guizhou Bailing Group Pharmaceutical Co .
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | CN¥9.02 Million | CN¥36.77 Million | ▼ -93.4% |
| 2022 | 3.69x | CN¥502.15 Million | CN¥135.97 Million | ▲ +32.6% |
| 2021 | 2.78x | CN¥324.92 Million | CN¥116.69 Million | ▲ +84.7% |
| 2020 | 1.51x | CN¥231.78 Million | CN¥153.73 Million | ▼ -5.4% |
| 2019 | 1.59x | CN¥467.41 Million | CN¥293.19 Million | ▲ +679.0% |
| 2018 | -0.28x | CN¥-157.45 Million | CN¥571.77 Million | ▼ -283.4% |
| 2017 | 0.15x | CN¥79.88 Million | CN¥532.03 Million | ▼ -84.4% |
| 2016 | 0.96x | CN¥466.62 Million | CN¥486.26 Million | ▼ -3.4% |
| 2015 | 0.99x | CN¥413.23 Million | CN¥416.15 Million | ▼ -21.0% |
| 2014 | 1.26x | CN¥395.83 Million | CN¥315.05 Million | ▲ +142.0% |
| 2013 | 0.52x | CN¥141.76 Million | CN¥272.99 Million | ▲ +508.9% |
| 2012 | 0.09x | CN¥19.52 Million | CN¥228.86 Million | ▼ -91.1% |
| 2011 | 0.96x | CN¥201.90 Million | CN¥209.98 Million | ▲ +134.0% |
| 2010 | -2.83x | CN¥-447.68 Million | CN¥158.20 Million | ▼ -352.2% |
| 2009 | 1.12x | CN¥125.31 Million | CN¥111.67 Million | ▲ +322.9% |
| 2008 | -0.50x | CN¥-40.42 Million | CN¥80.30 Million | ▲ +54.3% |
| 2007 | -1.10x | CN¥-79.37 Million | CN¥72.00 Million | — |